Why Every AI Lab Will Become a Biotech Company | Andrew Huberman
Patrick O'Shaughnessy interviews neuroscientist Andrew Huberman, who shares insights into managing energy, optimizing sleep, and the current state of public health and longevity. Huberman discusses the wild frontier of neurotechnology, including the massive implications of non-invasively reading and writing to the brain. He also explores why AI giants are actually biotech companies and the ethical realities of genetic engineering. The conversation covers topics from daily focus optimization to the future of human-computer interaction.
Original sources
YouTube Invest Like the Best
Video:Why Every AI Lab Will Become a Biotech Company | Andrew Huberman ↗
AI Radar wrote this summary from the publisher’s notes with AI, not from a transcript. How it works.